Login

Dr Stuart Quin, CEO of Medica Group PLC 00:00:00

Share On Facebook Share On Twitter

Dr Stuart Quin, CEO of Medica Group PLC, discusses the Group's first-half performance

Recent Videos

00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
00:10:00
James Anderson: Guanajuato Silver Expands with $50M Bolanitos Deal, Building Mexico’s Fastest-Growing Silver Producer|James Anderson,CHAIRMAN & CEO,Guanajuato Silver Company Ltd
00:10:00
Highland Copper Company Targets 2026 Construction Decision as Fully Permitted Copperwood Project Gains U.S. Federal Financing Momentum|Barry O’Shea,CEO,Highland Copper

Suggestions

00:10:00
struggling startups that need to grow and scale|Will Thomsen,Partner,Abstract Ventures
00:10:00
Allspring’s vision is to inspire a new era of investing that pursues both financial returns and positive outcomes. Diverse perspectives power our investment strategies through a unified platform and a commitment to our clients.| Joe Sullivan,Chief Executi
00:10:00
Why BWXT Chooses the Lynchburg Region: Insights from CEO Rex Geveden | Rex Geveden - CEO of BWX Technologies
00:10:00
Tony Fabrizi of Blue Star Capital plc announces plans to raise up to £900,000 to facilitate a strategic shift in direction.
00:10:00
VC Firm investing in the lifesciences|Daniel Yadegar,Chief Medical Officer,Newpath Partners
00:10:00
Critical Elements Lithium: Rose Project and Exploration Update
00:10:00
Exploration Potential in Newfoundland's Gold Rush: Exploits Discovery Overview
00:10:00
Privacy and Security Industry Trends and Reflections|Rak Garg,Principal,Bain Capital Ventures
00:10:00
The Book of Mormon: Dialogic Revelation and Christian Beliefs in the Western Hemispher|Terryl Givens,Professor,University of Richmond
00:10:00
Roxgold Gold: Advancing Discoveries and Resource Delineation in Mali
00:10:00
Pierre Barnabé from Soitec reaffirms the semiconductor company's roadmap for 2025-2026.
00:10:00
Investor Jenny Harrington is buying shares of Clearway Energy due to favorable valuation and growth prospects at current levels.

© 2017 - Neuhu+